The Knowledge Congress Has Scheduled a Live Webcast on Legal Series: Understanding FDAs Consent Form Requirements Live Webcast
Summary
Company Overview Contact Info & Offices Press Releases The Knowledge Group Press Release Receive press releases from The Knowledge Group: By Email RSS Feeds: The Knowledge Congress Has Scheduled a Live Webcast on Legal Series: Understanding FDAs Consent Form Requirements Live Webcast New York, NY, November 24, 2012 --( It has scheduled a live webcast entitled: “Legal Series: Understanding FDA’s Consent Form Requirements Live Webcast.” This two-hour event is scheduled on January 17, 2013 from 12:00 PM to 2:00 PM ET.Event Synopsis: The Food and Drug Administration issued a new consent form requirement for FDA-regulated clinical trials effective this March 7, 2012.The question now is how should the industry comply in a cost effective manner that does not compromise the integrity of the science.Speakers/Faculty Panel Harry Nelson, Co-Founder, Fenton Nelson Lisa Murtha, Esq., Partner, SNR Denton US LLP For further details about this event, please visit: http://www.knowledgecongress.org/event_2012_Consent_Form.html About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries.Contact information: The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series http://www.knowledgecongress.org info@knowledgecongress.org New York, NY, November 24, 2012 --( PR.com )-- The Knowledge Group/The Knowledge Congress Live Webcast Series, brings together the worlds leading authorities and industry participants through informative two-hour webcasts.It has scheduled a live webcast entitled: “Legal Series: Understanding FDA’s Consent Form Requirements Live Webcast.” This two-hour event is scheduled on January 17, 2013 from 12:00 PM to 2:00 PM ET.Event Synopsis:The Food and Drug Administration issued a new consent form requirement for FDA-regulated clinical trials effective this March 7, 2012.